...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient.
【24h】

Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient.

机译:多发性硬化症患者中β-干扰素诱导的深部红斑狼疮(狼疮性脂膜炎)。

获取原文
获取原文并翻译 | 示例
           

摘要

We report a patient with multiple sclerosis (MS) who developed subcutaneous nodules on the face, shoulders and extremities while being treated with interferon (IFN)-beta-1b. These nodules fluctuated in parallel with myelopathy, and were diagnosed as lupus erythematosus profundus (LEP) based on histopathological findings. The patient showed no relapse of either neurological symptoms or subcutaneous nodules after cessation of IFN-beta-1b. This agent can cause induration and necrosis in the sites of injection but also systemic skin lesions such as LEP ascribable to its immunomodulatory effects.
机译:我们报告了一名多发性硬化症(MS)患者,在接受干扰素(IFN)-β-1b治疗时在面部,肩膀和四肢出现皮下结节。这些结节与脊髓病并行波动,并根据组织病理学发现被诊断为深部红斑狼疮(LEP)。停止使用IFN-β-1b后,患者未出现神经系统症状或皮下结节复发。该药物可引起注射部位的硬结和坏死,还可能由于免疫调节作用而导致全身性皮肤病变,如LEP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号